Document is current
Any future updates will be listed below
-
Authors
Song, Jayeon
Cho, Mi Hyeon
Cho, Hayoung
Song, Younseong https://orcid.org/0000-0001-5296-044X
Lee, Sung Woon https://orcid.org/0000-0003-0362-9982
Nam, Ho Chul https://orcid.org/0009-0009-9646-5761
Yoon, Tae Ho
Shin, Jong Cheol
Hong, Jae-Sang
Kim, Yejin
Ekanayake, Emil
Jeon, Jueun
You, Dong Gil
Im, Sung Gap
Choi, Gyu-Seog
Park, Jun Seok
Carter, Bob C.
Balaj, Leonora https://orcid.org/0000-0003-0931-9715
Seo, An Na
Miller, Miles A. https://orcid.org/0000-0001-7638-8898
Park, Soo Yeun
Kang, Taejoon https://orcid.org/0000-0002-5387-6458
Castro, Cesar M.
Lee, Hakho https://orcid.org/0000-0002-0087-0909
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA284982, R01CA264363, 1U01CA279858, U01CA284982)
National Research Foundation of Korea (2021R1A2B5B03001416, 2021R1A2C1005342, 2021M3E5E3080379, 2023R1A2C2005185)
Korea Health Industry Development Institute (HR22C1832)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP2CA259675)
- License Information
-
More Information
Article History
Received: 20 February 2024
Accepted: 9 September 2024
First Online: 7 October 2024
Competing interests
: J.S., T.K., C.M.C. and H.L. declare the filing of a provisional patent that was assigned to and handled by Massachusetts General Hospital and the Korea Research Institute of Bioscience and Biotechnology. M.A.M. declares research support from Ionis Pharmaceuticals, Genentech and Pfizer, all of which are unrelated to the present paper. The other authors declare no competing interests.
